Dongguan Aier Eye Hospital: One City, Three Hospitals and One Clinic, Part of a Global Network
0769-39003909 0769-39003909 
From October 24 to 26, 2025, a high‑profile academic gala assembling top‑tier ophthalmology expertise — the 11th Chinese Dry Eye Congress, the 9th Chinese Ocular Surface & Tear Film Diseases Congress, the 9th National Academic Conference on Traditional‑Chinese‑Medicine‑based Eye Health Care, together with the 4th Ophthalmic Drug Innovation Forum (CDEC 2025) — grandly kicked off in Beijing, China’s capital. This cross‑disciplinary high‑level conference stands not only as an annual highlight in the field of dry‑eye disorders, but also as a vital platform for boosting exchanges and integration among relevant ophthalmic disciplines.
As one of the representatives of the ophthalmology community in Dongguan, Yuan Yuzong, Director of the General Ophthalmology Department at Dongguan Humen Aier Eye Hospital, was invited to attend the conference. Drawing on practical clinical experience and technical insights in the diagnosis and treatment of ocular‑surface and tear‑film diseases in China, he engaged in in‑depth exchanges with domestic counterparts on cutting‑edge advances in ocular‑surface disorders and visual science, showcasing the developmental achievements of Dongguan ophthalmology on the national stage.
During the conference, Director Yuan Yuzong focused intensively on precise dry‑eye testing and anti‑inflammatory therapy and took part in in‑depth discussions on these topics. Dry‑eye diagnosis and treatment has now entered an era characterized by precision, full‑cycle management and multidisciplinary participation. Mechanism‑oriented approaches are required to advance the in‑depth integration of anti‑inflammatory therapy and multi‑scenario clinical management.
Inflammation is the core pathophysiological process of dry eye. Aggravated inflammation will further unbalance and damage the ocular surface microenvironment of dry eye patients. This key viewpoint enabled Director Yuan Yuzong to further recognize that anti-inflammation is a core component of dry eye treatment, which requires in-depth professional assessment and precise individualized treatment.
In addition, Director Yuan Yuzong actively took part in the special session In‑depth Interpretation of Common Ocular‑Surface and Corneal Surgical Procedures. Chaired and presented by Professor Li Shaowei, Group Leader of the Ocular‑Surface and Corneal Disease Specialty Group of Aier Eye Hospital Group, this session delivered valuable clinical experience to the conference. It focused on core surgical essentials, refined operational details and the management of complex and challenging cases, with special attention to technically demanding procedures such as corneal endothelium stripping in young and middle‑aged patients.
Drawing on more than ten years of ophthalmic clinical experience and hands‑on expertise in ocular‑surface surgery, Director Yuan Yuzong held in‑depth discussions with domestic experts. He put forward his insights on reducing postoperative complications and optimizing management strategies, while absorbing advanced approaches shared by fellow practitioners across the country. These exchanges helped build cutting‑edge consensus for refining postoperative diagnosis‑and‑treatment workflows and improving patient prognosis.
Director Yuan also holds key industry positions. He works as a preceptor for the “Jingzhi Pterygium Surgery” training program of Aier Eye Hospital Group and an assessment expert for corneal and ocular‑surface surgeries in Guangdong Province. Meanwhile, he serves as a committee member of the Cornea, Ocular‑Surface and Lacrimal‑Duct Specialty Group for Aier Eye Hospital’s Guangdong regional division. He will keep promoting the development of regional eye‑health services in the days ahead.
His invitation to CDEC 2025 marks not only national recognition of his personal academic prowess, but also a highlight moment for Dongguan ophthalmology to engage in top‑level national academic dialogue. In the future, Director Yuan will continue to introduce cutting‑edge technologies and advanced concepts, deepen clinical practice, and advance scientific research. He is committed to upgrading regional dry eye diagnosis and treatment standards and safeguarding the clear vision of every patient.
咨询电话：
0769-39003909
医院地址：
东莞市虎门镇虎门大道123号
